Article
The CC genotype of transforming growth factor-β1 increases the risk of late-onset Alzheimer's disease and is associated with AD-related depression.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology - 1 Apr 2012
Caraci Filippo, Bosco Paolo, Signorelli Maria, Spada Rosario S, Cosentino Filomena I, Toscano Giuseppe, Bonforte Cinzia, Muratore Stefano, Prestianni Giuseppina, Panerai Simonetta, Giambirtone Maria Concetta, Gulotta Eleonora, Romano Carmelo, Salluzzo Maria Grazia, Nicoletti Ferdinando, Copani Agata, Drago Filippo, Aguglia Eugenio, Ferri Raffaele
Abstract excerpt
Transforming growth factor-β1 (TGF-β1) is a neurotrophic factor that exerts neuroprotective effects against β-amyloid-induced neurodegeneration. Recently, a specific impairment of the TGF-β1 signaling pathway has been demonstrated in Alzheimer's disease (AD) brain. TGF-β1 is also involved in the pathogenesis of depressive disorders, which may occur in 30-40% of AD patients. The TGF-β1 gene contains single...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
